TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Functional Independence Measure (FIM) scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of poor bowel cleansing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of participants with COPD exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency of systemic polysaccharide specific B cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients responding to the ASAS 20 criterion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirement of continuous venovenous hemodiafiltration (CVVHDF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Acute renal failure prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Treatment effectiveness of norethisterone acetate vs expectant management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCSF Response on Bile flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: GCSF Response on transplant-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of Responders in Voiding Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mothers' perceptions on support at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Infant's development at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infant's health at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety (Cardiac tamponade)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety (Stroke)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety (Bleeding)
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma CRP kinetic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gaze evoked nystagmus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: down beat nystagmus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: rebound nystagmus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in plasma norepinephrine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in plasma epinephrine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in plasma cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in myoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in bile acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of Treatment-Related Adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Local progression-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Rate of lactate clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean change in patient activation score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of pregnant women with pregnancy related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of offsprings with adverse birth outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients achieving at least 75% reduction in Eczema Area and Severity Index [EASI]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Mindful Attention Awareness Scale (MAAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in resource-workload-balance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in HRV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of the optic nerve sheath diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Oxidation rate of lipid substrates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of Integrase Drug Resistance Mutations (INSTI DRMs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of INSTI DRMs per patient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge of cardiovascular disease risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Social Knowledge Assessment (SKA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Occurrence of developing of Neovascular Age-Related Macular Degeneration (wAMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in the Visual Acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the size of the GA lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Presence of oral cancer or oral potentially malignant lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: (Re)admission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rates of SBDOH screen completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Stimulated cytokine/chemokine measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Inflammation with physical and mental health outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glaucoma Treatment Compliance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: End of Treatment Complete Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: number of participants with pruritus
Endpoint domain: Adverse events/effects
Primary endpoint: Stress response (serum cortisol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Immune response (neutrophil to lymphocyte ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immune response (platelet to lymphocyte ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in child's school readiness skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in parent confidence teaching math and literacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: scar mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective response of intrahepatic lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Hunger Visual Analogue Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfied Visual Analogue Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fullness Visual Analogue Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: How much can you eat Visual Analogue Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory variations of subclavian vein diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of Participants Screened Compared to Number of Eligible Participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Eligible Participants Compared to Number of Enrolled Participants
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Days to Hospital Day of Enrollment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants in the Intervention Group Who Were Able to Receive the Full Enhanced Opioid Stewardship Intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants in Intervention Group Who Complete the Peri-discharge Evaluation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in BARC-10 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of clopidogrel prescription in patients with T2D
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prevalence of ticagrelor and prasugrel prescription in patients with T2D vs. clopidogrel
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: MedWise Risk Score for T2D patients
Endpoint domain: Adverse events/effects
Primary endpoint: Localization of breast tumor marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Correlation with quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in the Inventory of Complicated Grief (ICG)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Beck Depression Inventory - Second Edition
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Modifications in alpha and beta diversity of stool microbiome profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood pressure phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of post-operative urinary retention (POUR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in ultrasound score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of (m)-GCN+TTF
Endpoint domain: Adverse events/effects
Primary endpoint: arterial pulses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: temporal pattern of pulse changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PSA evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Plasma Pharmacokinetics of Monepantel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Plasma Pharmacokinetics of Monepantel Sulfone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Depression-related stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effect of therapeutic STN-DBS on decision making and impulse control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive rhino-conjunctivitis response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of SIM0417 in cohort 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of SIM0417 in cohort 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t1/2 of SIM0417 in cohort 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of heartburn resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: quality of functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: supportive care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Success of program dissemination
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Satisfaction of financial health educational program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness of community based education
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Frequency and severity of abnormal findings in electrocardiograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency and severity of abnormal findings of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of all-cause mortality at 30 days post implantation
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants diagnosed with heart failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of outpatient HF visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of HF hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Bilirubin test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in the number of participants who self-reported quitting betel quid chewing at Day-22
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in the number of participants who self-reported quitting betel quid chewing at Month-3
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Gut microbiota signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ECOG performance score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean accuracy of SEPS placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of Secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Population Doubling Rate of keratinocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Population Doubling Rate of fibroblasts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxford Shoulder Score (OSS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean difference between eGFR and serum creatinine measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Analgesia efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oGTT derived plasma AUC0-120 min of glucose, insulin, c-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in MMTT derived plasma AUC0-240 min of glucose, insulin, c-peptide and β-cell responsivity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of MCMs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Adverse Neonatal and Infant Outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with Hypertensive Disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Stillbirths, Preterm Births, and Medically Attended Spontaneous Abortions
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants with Adverse Events Related to Interstitial Lung Disease
Endpoint domain: Adverse events/effects
Primary endpoint: Rates and types of severe or serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of all adult female worms that are fertile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Asthma Quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Loss of sight for more than 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of a multi-level telehealth-based intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short Form (SF)-36 Physical Component Summary (PCS) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Phagocytosis activity by granulocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of participants reporting Newly Diagnosed Chronic Medical Conditions (NDCMCs)
Endpoint domain: Adverse events/effects
Primary endpoint: Quantitative characteristics of CD8+ Eomes+ KIR+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Phenotypic characteristics of CD8+ Eomes+ KIR+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Functionality of CD8+ Eomes+ KIR+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Prevalence of obesity in patients with type 1 diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cerebral Hemodynamic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 7-day point prevalence of self-reported, and CO verified, smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of oropharyngeal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of dysphagia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapy acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subject perception of MPT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative clinical pregnancy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Accuracy of intra-ocular lens power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of in-hospital mortality
Endpoint domain: Mortality/survival
Primary endpoint: Neoplasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: bone health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Lipid profile (total cholesterol, LDL cholesterol concentrations)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difference in absolute and relative tidal volumes at deep sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difference in absolute and relative MRI-derived anteroposterior transpharyngeal distances at deep sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Difference in adjuvant use of manual airway support during PS according to SOC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ultrasonographic Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of face to face consultation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of therapeutic modifications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Safety Level
Endpoint domain: Adverse events/effects
Primary endpoint: Knee Injury and Osteoarthritis Outcome Score (KOOS) knee subjective score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis index (WOMAC) subjective score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: International Knee Documentation Committee (IKDC) objective form
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement (HOOS-JR) hip subjective score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: All bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Facial Fat Volume Retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global well-being assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of aneurysms with adequate occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Achievement of Optimal PTA in Percent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Melatonin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Positive rate of preoperative MRD test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Navicular Height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of obesity related to androgen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Severity of obesity related to cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cardiovascular risk in obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Willingness to receive COVID-19 vaccine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knee related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CAOD index of caries severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunometabolic responses in immune cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decreased abdominal girth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine effectiveness on pneumococcal CAP
Endpoint domain: Mortality/survival
Primary endpoint: 5-D Itch Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing